首页> 外文期刊>The Journal of Urology >Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
【24h】

Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.

机译:肾细胞癌中肾周脂肪浸润和肿瘤大小的预后意义。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSES: It is controversial that perinephric fat infiltration has an impact on survival in patients with renal cell carcinoma. Therefore, we evaluated the influence of perinephric fat infiltration and tumor size on patient survival. MATERIALS AND METHODS: We retrospectively reviewed the medical records of 783 and 77 patients with pT1-2 (cN0M0) and pT3a (cN0M0) renal cell carcinoma, respectively. Sporadic unilocular noncystic renal cell carcinoma was included. Univariate and multivariate analyses of prognostic factors, including perinephric fat infiltration, on cancer specific and disease-free survival were performed. Median followup was 56.0 months after surgery. RESULTS: Patients with pT1-2 and pT3a tumors had a 5-year cancer specific survival rate of 96.1% and 84.9%, and a 5-year disease-free survival rate of 93.4% and 74.7%, respectively (each p 0.01). Age, tumor size and Fuhrman nuclear grade were independent prognostic factors for cancer specific and disease-free survival, whereas perinephric fat infiltration was significant only for disease-free survival. However, perinephric fat infiltration had a significant effect on cancer specific survival in patients with pT3a tumors more than 7 cm (p = 0.001). In contrast, patients with pT3a tumors 7 cm or less had cancer specific and disease-free survival similar to that of patients with pT2 tumors. Recurrence of pT3a tumors greater than 7 cm was observed in 44% of patients but in only 14.6% of those with pT3a tumors 7 cm or less (p = 0.029). In contrast to the recurrence of tumors 7 cm or less, recurrence of pT3a tumors more than 7 cm usually developed at multiple sites with a large tumor burden and it progressed rapidly. Consequently 85% of patients with recurrence of pT3a tumors larger than 7 cm died of renal cell carcinoma compared with 33% of those with recurrence of pT3a tumors 7 cm or less (p = 0.001). CONCLUSIONS: In pT3a renal cell carcinoma tumor size was the strongest prognostic factor of disease-free and cancer specific survival. Perinephric fat infiltration was an independent prognostic factor for disease-free survival but not for cancer specific survival due to the less aggressive behavior of small (7 cm or less) pT3a tumors after recurrence. Tumor size and perinephric fat infiltration should be included in T3a renal cell carcinoma staging.
机译:目的:有争议的是肾上腺脂肪浸润会影响肾细胞癌患者的生存。因此,我们评估了肾周脂肪浸润和肿瘤大小对患者生存的影响。材料与方法:我们回顾性分析了783例和77例pT1-2(cN0M0)和pT3a(cN0M0)肾细胞癌的患者的病历。包括散发的单眼非囊性肾细胞癌。对癌症特异性和无病生存期的预后因素(包括肾周脂肪浸润)进行单因素和多因素分析。中位随访时间为手术后56.0个月。结果:患有pT1-2和pT3a肿瘤的患者的5年癌症特异性生存率分别为96.1%和84.9%,以及5年无病生存率分别为93.4%和74.7%(每个p <0.01) 。年龄,肿瘤大小和福尔曼核分级是癌症特异性和无病生存的独立预后因素,而肾周脂肪浸润仅对无病生存有意义。然而,肾上腺脂肪浸润对pT3a肿瘤大于7 cm的患者的癌症特异性存活率有显着影响(p = 0.001)。相反,pT3a肿瘤小于或等于7 cm的患者具有与pT2肿瘤患者相似的癌症特异性和无病生存期。在44%的患者中观察到大于7 cm的pT3a肿瘤复发,但在7 cm或更小的pT3a肿瘤患者中只有14.6%的患者复发(p = 0.029)。与7cm以下的肿瘤复发相比,pT3a肿瘤的复发通常在多处,肿瘤负担大的多个部位发展而超过7cm,并且进展迅速。因此,pT3a肿瘤复发大于7 cm的患者中有85%死于肾细胞癌,而pT3a肿瘤复发小于等于7 cm的患者中有33%(p = 0.001)。结论:在pT3a肾细胞癌中,肿瘤的大小是无病生存和癌症特异性生存的最强预后因素。肾周脂肪浸润是无疾病生存的独立预后因素,但由于小(7 cm或更小)pT3a肿瘤复发后的侵略性较弱,因此不是癌症特异性生存的预后因素。 T3a肾细胞癌分期应包括肿瘤大小和肾周脂肪浸润。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号